美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Intensity Therapeutics, Inc.

4.80

-0.0650-1.34%

成交量：2.47万

成交额：11.58万

市值：1,565.52万

市盈率：-1.00

高：4.84

开：4.57

低：4.57

收：4.86

52周最高：43.50

52周最低：3.51

股本：326.49万

流通股本：303.89万

量比：0.93

换手率：0.81%

股息：- -

股息率：- -

每股收益(TTM):-4.8026

每股收益(LYR):-8.5567

净资产收益率：-195.88%

总资产收益率：-89.91%

市净率：1.70

市盈率(LYR):-0.56

数据加载中...

总览公司新闻资讯公告

Intensity Therapeutics重启三阴性乳腺癌术前随机二期临床试验患者治疗（Invincible-4研究）

Intensity Therapeutics推进软组织肉瘤与术前三阴性乳腺癌的晚期临床研究

Intensity Therapeutics公司——Int230-6研究完成，患者入组超200例，成果经同行评审发表

Intensity Therapeutics发布年中进展，重点阐述Int230-6晚期研发项目与战略合作机遇

Intensity Therapeutics, Inc.：Benchmark将目标价调整至12美元，此前为1.50美元，以反映并股影响

Intensity Therapeutics公布2025财年业绩亮点及企业动态更新

Intensity Therapeutics公司宣布扩大ATM融资机制旨在提升财务灵活性

BUZZ--美国股票走势-Natera、Pacira 生物科学公司、Kezar 生命科学公司

BUZZ-乳腺癌药物初显疗效，Intensity Therapeutics 股价上涨

Intensity Therapeutics公司初步Invincible-4研究显示：INT230-6联合标准疗法病理完全缓解率达71.4%，单独标准疗法为33%

Intensity Therapeutics公司提议修改方案：降低药物剂量并采用单次Int230-6注射

Intensity Therapeutics Inc 向瑞士药监局及伦理委员会提交方案修订，拟重启Invincible-4研究入组

Intensity Therapeutics, Inc. 公布其二期术前三阴性乳腺癌Invincible-4研究最新进展

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/INTS/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INTS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INTS\",,,,,undefined,":{"symbol":"INTS","market":"US","secType":"STK","nameCN":"Intensity Therapeutics, Inc.","latestPrice":4.795,"timestamp":1787600338739,"preClose":4.86,"halted":0,"volume":24673,"delay":0,"changeRate":-0.013374485596707899,"floatShares":3038900,"shares":3264900,"eps":-4.802551,"marketStatus":"交易中","change":-0.065,"latestTime":"08-24 15:40:58 EDT","open":4.57,"high":4.8409,"low":4.57,"amount":115816.83845600001,"amplitude":0.055741,"askPrice":4.87,"askSize":100,"bidPrice":4.7,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-4.802551,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"listingDate":1666324800000,"exchange":"NASDAQ","adjPreClose":4.86,"preHourTrading":{"tag":"盘前","latestPrice":4.48,"preClose":4.86,"latestTime":"05:42 EDT","volume":9,"amount":40.32000000000001,"timestamp":1787564574969,"change":-0.38,"changeRate":-0.078189,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":4.86,"preClose":4.86,"latestTime":"19:30 EDT","volume":88,"amount":411.71,"timestamp":1787355006356,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.930614},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INTS\",,,,,undefined,":{"symbol":"INTS","floatShares":3038900,"roa":"-89.91%","roe":"-195.88%","lyrEps":-8.556737,"volumeRatio":0.930614,"shares":3264900,"dividePrice":0,"high":4.8409,"amplitude":0.055741,"preClose":4.86,"low":4.57,"week52Low":3.51,"pbRate":"1.70","week52High":43.5,"institutionHeld":0,"latestPrice":4.795,"committee":-0.904762,"eps":-4.802551,"divideRate":0,"volume":24673,"delay":0,"ttmEps":-4.802551,"open":4.57,"prevYearClose":10.255,"prevWeekClose":4.86,"prevMonthClose":4.15,"prevQuarterClose":4.1,"fiveDayClose":4.15,"twentyDayClose":4.57,"sixtyDayClose":4.42},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INTS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"INTS","fiscalQuarterEnding":"2026/06","expectedEps":-0.81,"name":null,"time":"盘前","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"pre","actualEps":-1.11},{"market":"US","date":"2026-02-19","symbol":"INTS","defaultRemindTime":1771511400000,"type":"split","dateTimestamp":1771477200000,"forFactor":25,"toFactor":1,"ratio":25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INTS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INTS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":5,"updateTime":1774929600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INTS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INTS","date":"2026-08-21","current":-0.998428,"percent":0.677588,"low":-15.25821,"twenty":-5.454128,"median":-2.154445,"eighty":-1.104352,"high":-0.31723,"avg":-3.557091,"sd":3.1686,"marketCap":15932609},"quantilePoints":[{"date":"2022-10-20","current":-9.173693,"twenty":-9.173693,"median":-9.173693,"eighty":-9.173693,"marketCap":80934718},{"date":"2023-07-07","current":-12.000673,"twenty":-12.000673,"median":-11.893737,"eighty":-9.173693,"marketCap":78596262},{"date":"2023-07-14","current":-11.805305,"twenty":-12.014248,"median":-11.893737,"eighty":-11.600651,"marketCap":77316730},{"date":"2023-07-21","current":-12.682867,"twenty":-12.306769,"median":-11.947205,"eighty":-11.660654,"marketCap":83064168},{"date":"2023-07-28","current":-11.867988,"twenty":-12.682867,"median":-12.014248,"eighty":-11.805305,"marketCap":77727261},{"date":"2023-08-04","current":-12.81868,"twenty":-12.682867,"median":-12.066484,"eighty":-11.867988,"marketCap":83953652},{"date":"2023-08-11","current":-12.933599,"twenty":-12.933599,"median":-12.306769,"eighty":-11.888882,"marketCap":84706293},{"date":"2023-08-18","current":-9.652146,"twenty":-12.81868,"median":-12.1197,"eighty":-11.660654,"marketCap":80327292},{"date":"2023-08-25","current":-9.800135,"twenty":-12.808233,"median":-12.000673,"eighty":-9.800135,"marketCap":81558886},{"date":"2023-09-01","current":-9.487714,"twenty":-12.770623,"median":-11.912204,"eighty":-9.783692,"marketCap":78958855},{"date":"2023-09-08","current":-9.093078,"twenty":-12.755579,"median":-11.893737,"eighty":-9.638992,"marketCap":75674604},{"date":"2023-09-15","current":-8.073601,"twenty":-12.70794,"median":-11.836647,"eighty":-9.487714,"marketCap":67190291},{"date":"2023-09-22","current":-6.034647,"twenty":-12.632721,"median":-11.600651,"eighty":-9.000996,"marketCap":50221663},{"date":"2023-09-29","current":-6.626601,"twenty":-12.586753,"median":-9.923459,"eighty":-8.293939,"marketCap":55148039},{"date":"2023-10-06","current":-7.251442,"twenty":-12.570873,"median":-9.800135,"eighty":-7.560574,"marketCap":60348102},{"date":"2023-10-13","current":-6.626601,"twenty":-12.448015,"median":-9.783692,"eighty":-7.192246,"marketCap":55148039},{"date":"2023-10-20","current":-4.636976,"twenty":-12.331842,"median":-9.61926,"eighty":-6.745518,"marketCap":38589943},{"date":"2023-10-23","current":-4.96584,"twenty":-12.319306,"median":-9.578152,"eighty":-6.686849,"marketCap":41326818},{"date":"2023-11-03","current":-4.932954,"twenty":-12.157898,"median":-9.487714,"eighty":-6.567406,"marketCap":41053131},{"date":"2023-11-10","current":-4.609845,"twenty":-12.119112,"median":-9.173693,"eighty":-6.48519,"marketCap":38364150},{"date":"2023-11-17","current":-3.237228,"twenty":-12.035142,"median":-8.862874,"eighty":-6.287872,"marketCap":28737191},{"date":"2023-11-24","current":-3.590621,"twenty":-12.006103,"median":-8.517567,"eighty":-5.189368,"marketCap":31874301},{"date":"2023-12-01","current":-3.784438,"twenty":-11.971208,"median":-8.209257,"eighty":-5.01517,"marketCap":33594828},{"date":"2023-12-08","current":-6.177413,"twenty":-11.939029,"median":-7.613192,"eighty":-5.01517,"marketCap":54837508},{"date":"2023-12-15","current":-12.447487,"twenty":-12.056037,"median":-8.209257,"eighty":-5.034902,"marketCap":110497578},{"date":"2023-12-22","current":-9.544103,"twenty":-12.056037,"median":-8.517567,"eighty":-5.074891,"marketCap":84723949},{"date":"2023-12-29","current":-12.200391,"twenty":-12.097826,"median":-8.854652,"eighty":-5.093498,"marketCap":108304078},{"date":"2024-01-05","current":-12.586479,"twenty":-12.221667,"median":-9.093078,"eighty":-5.095649,"marketCap":111731422},{"date":"2024-01-12","current":-9.080797,"twenty":-12.136622,"median":-9.173576,"eighty":-5.162954,"marketCap":80611136},{"date":"2024-01-19","current":-7.443783,"twenty":-12.119504,"median":-9.086938,"eighty":-5.189368,"marketCap":66079197},{"date":"2024-01-26","current":-6.94959,"twenty":-12.056037,"median":-8.862874,"eighty":-5.265897,"marketCap":61692196},{"date":"2024-02-02","current":-7.706323,"twenty":-12.006103,"median":-8.582973,"eighty":-5.358906,"marketCap":68409791},{"date":"2024-02-09","current":-5.497898,"twenty":-11.971208,"median":-8.279141,"eighty":-5.454656,"marketCap":48805382},{"date":"2024-02-16","current":-4.67939,"twenty":-11.939029,"median":-8.106172,"eighty":-5.189368,"marketCap":41539412},{"date":"2024-02-23","current":-4.63306,"twenty":-11.915897,"median":-7.791263,"eighty":-5.065946,"marketCap":41128131},{"date":"2024-03-01","current":-5.714107,"twenty":-11.893737,"median":-7.613192,"eighty":-5.065946,"marketCap":50724694},{"date":"2024-03-08","current":-8.617491,"twenty":-11.891795,"median":-7.659757,"eighty":-5.094215,"marketCap":76498323},{"date":"2024-03-15","current":-6.42451,"twenty":-11.880524,"median":-7.613192,"eighty":-5.12966,"marketCap":57031008},{"date":"2024-03-22","current":-7.168217,"twenty":-11.842915,"median":-7.462714,"eighty":-5.183371,"marketCap":75538667},{"date":"2024-03-28","current":-6.569781,"twenty":-11.793205,"median":-7.382998,"eighty":-5.190398,"marketCap":69232353},{"date":"2024-04-05","current":-6.062412,"twenty":-11.727976,"median":-7.320234,"eighty":-5.219219,"marketCap":63885696},{"date":"2024-04-12","current":-5.919308,"twenty":-11.648653,"median":-7.270395,"eighty":-5.328019,"marketCap":62377665},{"date":"2024-04-19","current":-4.956607,"twenty":-11.467325,"median":-7.168217,"eighty":-5.219219,"marketCap":52232726},{"date":"2024-04-26","current":-5.106216,"twenty":-10.872247,"median":-7.057617,"eighty":-5.181486,"marketCap":53809304},{"date":"2024-05-03","current":-5.203787,"twenty":-10.575732,"median":-7.004794,"eighty":-5.110119,"marketCap":54837508},{"date":"2024-05-10","current":-4.89156,"twenty":-10.334812,"median":-6.920091,"eighty":-5.07751,"marketCap":51547257},{"date":"2024-05-17","current":-5.064674,"twenty":-10.138832,"median":-6.816961,"eighty":-5.04775,"marketCap":69917822},{"date":"2024-05-24","current":-5.034882,"twenty":-10.040205,"median":-6.769756,"eighty":-5.01517,"marketCap":69506541},{"date":"2024-05-31","current":-4.905782,"twenty":-10.013896,"median":-6.720408,"eighty":-4.982612,"marketCap":67724322},{"date":"2024-06-07","current":-4.945811,"twenty":-9.945635,"median":-6.626601,"eighty":-4.965367,"marketCap":68276920},{"date":"2024-06-14","current":-4.747756,"twenty":-9.859151,"median":-6.577272,"eighty":-4.943699,"marketCap":65542772},{"date":"2024-06-21","current":-4.638498,"twenty":-9.834825,"median":-6.527942,"eighty":-4.905297,"marketCap":64034465},{"date":"2024-06-28","current":-4.887408,"twenty":-9.833021,"median":-6.527942,"eighty":-4.896744,"marketCap":67470661},{"date":"2024-07-05","current":-4.817184,"twenty":-9.806712,"median":-6.504734,"eighty":-4.887289,"marketCap":66501232},{"date":"2024-07-12","current":-4.986137,"twenty":-9.800135,"median":-6.468725,"eighty":-4.878216,"marketCap":68833622},{"date":"2024-07-15","current":-5.055665,"twenty":-9.800135,"median":-6.445726,"eighty":-4.87855,"marketCap":69793453},{"date":"2024-08-02","current":-4.807351,"twenty":-9.796846,"median":-6.435118,"eighty":-4.877213,"marketCap":66365484},{"date":"2024-08-09","current":-4.588835,"twenty":-9.783692,"median":-6.41284,"eighty":-4.86516,"marketCap":63348871},{"date":"2024-08-16","current":-3.955696,"twenty":-9.783692,"median":-6.339457,"eighty":-4.820512,"marketCap":59632119},{"date":"2024-08-23","current":-3.896315,"twenty":-9.757383,"median":-6.270563,"eighty":-4.807351,"marketCap":58736948},{"date":"2024-08-30","current":-3.86434,"twenty":-9.645569,"median":-6.204474,"eighty":-4.781352,"marketCap":58254933},{"date":"2024-09-06","current":-3.910018,"twenty":-9.61926,"median":-6.112191,"eighty":-4.747756,"marketCap":58943526},{"date":"2024-09-13","current":-3.837391,"twenty":-9.544103,"median":-6.034647,"eighty":-4.707926,"marketCap":57848664},{"date":"2024-09-20","current":-3.727307,"twenty":-9.537044,"median":-5.97785,"eighty":-4.668296,"marketCap":56189156},{"date":"2024-09-27","current":-3.316207,"twenty":-9.52866,"median":-5.925812,"eighty":-4.63306,"marketCap":49991822},{"date":"2024-10-04","current":-3.2888,"twenty":-9.487714,"median":-5.784184,"eighty":-4.588835,"marketCap":49578667},{"date":"2024-10-11","current":-3.037299,"twenty":-9.487714,"median":-5.559672,"eighty":-4.472545,"marketCap":45787276},{"date":"2024-10-18","current":-2.923378,"twenty":-9.487714,"median":-5.461423,"eighty":-4.216084,"marketCap":44069926},{"date":"2024-10-25","current":-2.923378,"twenty":-9.26612,"median":-5.333882,"eighty":-3.973967,"marketCap":44069926},{"date":"2024-10-31","current":-2.786345,"twenty":-9.192178,"median":-5.307863,"eighty":-3.960154,"marketCap":42004148},{"date":"2024-11-08","current":-2.941649,"twenty":-9.173693,"median":-5.199834,"eighty":-3.926462,"marketCap":44345363},{"date":"2024-11-15","current":-2.689442,"twenty":-9.173505,"median":-5.189027,"eighty":-3.893574,"marketCap":43725630},{"date":"2024-11-22","current":-2.507825,"twenty":-9.109154,"median":-5.115973,"eighty":-3.863938,"marketCap":40772862},{"date":"2024-11-29","current":-2.717615,"twenty":-9.085709,"median":-5.101291,"eighty":-3.84881,"marketCap":44185701},{"date":"2024-12-06","current":-2.321954,"twenty":-9.052999,"median":-5.073692,"eighty":-3.799491,"marketCap":37752650},{"date":"2024-12-13","current":-1.917562,"twenty":-8.931511,"median":-5.06017,"eighty":-3.723653,"marketCap":31177648},{"date":"2024-12-20","current":-1.857563,"twenty":-8.853008,"median":-5.047673,"eighty":-3.619065,"marketCap":30202120},{"date":"2024-12-27","current":-1.764685,"twenty":-8.767209,"median":-5.021654,"eighty":-3.573099,"marketCap":28692014},{"date":"2025-01-03","current":-1.625368,"twenty":-8.642201,"median":-5.01517,"eighty":-3.513045,"marketCap":26426855},{"date":"2025-01-10","current":-1.838802,"twenty":-8.617491,"median":-5.008645,"eighty":-3.463472,"marketCap":29897078},{"date":"2025-01-17","current":-2.572725,"twenty":-8.517567,"median":-4.984374,"eighty":-3.373331,"marketCap":41829936},{"date":"2025-01-24","current":-2.370715,"twenty":-8.346557,"median":-4.965604,"eighty":-3.310726,"marketCap":38545455},{"date":"2025-01-31","current":-2.053117,"twenty":-8.284074,"median":-4.956607,"eighty":-3.212827,"marketCap":33381630},{"date":"2025-02-07","current":-2.238919,"twenty":-8.253306,"median":-4.940989,"eighty":-3.06772,"marketCap":36402592},{"date":"2025-02-14","current":-2.015957,"twenty":-8.160869,"median":-4.905782,"eighty":-3.026792,"marketCap":32777437},{"date":"2025-02-21","current":-2.043827,"twenty":-8.138995,"median":-4.896744,"eighty":-3.006493,"marketCap":33230582},{"date":"2025-02-28","current":-2.099568,"twenty":-8.099657,"median":-4.889484,"eighty":-2.934341,"marketCap":34136870},{"date":"2025-03-07","current":-2.146018,"twenty":-8.038556,"median":-4.87855,"eighty":-2.919724,"marketCap":34892111},{"date":"2025-03-14","current":-2.159953,"twenty":-8.005927,"median":-4.871913,"eighty":-2.813752,"marketCap":35118683},{"date":"2025-03-21","current":-1.801034,"twenty":-7.907089,"median":-4.866947,"eighty":-2.682321,"marketCap":29299223},{"date":"2025-03-28","current":-1.800101,"twenty":-7.780452,"median":-4.846639,"eighty":-2.622879,"marketCap":29284042},{"date":"2025-04-04","current":-1.82903,"twenty":-7.718678,"median":-4.817184,"eighty":-2.548971,"marketCap":29754652},{"date":"2025-04-11","current":-1.810366,"twenty":-7.669259,"median":-4.807351,"eighty":-2.494707,"marketCap":29451033},{"date":"2025-04-17","current":-1.735712,"twenty":-7.632006,"median":-4.806913,"eighty":-2.414832,"marketCap":28236557},{"date":"2025-04-25","current":-0.839954,"twenty":-7.607202,"median":-4.796544,"eighty":-2.376882,"marketCap":13664368},{"date":"2025-05-02","current":-0.521647,"twenty":-7.551589,"median":-4.752722,"eighty":-2.245719,"marketCap":8486148},{"date":"2025-05-09","current":-0.530045,"twenty":-7.466501,"median":-4.747756,"eighty":-2.177388,"marketCap":8622776},{"date":"2025-05-16","current":-0.505526,"twenty":-7.426042,"median":-4.707976,"eighty":-2.157166,"marketCap":7588954},{"date":"2025-05-23","current":-0.365063,"twenty":-7.386285,"median":-4.686306,"eighty":-2.149257,"marketCap":5480321},{"date":"2025-05-30","current":-0.393378,"twenty":-7.360388,"median":-4.668296,"eighty":-2.119771,"marketCap":5905387},{"date":"2025-06-06","current":-0.549666,"twenty":-7.332589,"median":-4.637737,"eighty":-2.099568,"marketCap":8251593},{"date":"2025-06-13","current":-0.392181,"twenty":-7.316341,"median":-4.63306,"eighty":-2.056833,"marketCap":5887424},{"date":"2025-06-20","current":-0.532797,"twenty":-7.300771,"median":-4.609845,"eighty":-2.053117,"marketCap":7998351},{"date":"2025-06-27","current":-0.511084,"twenty":-7.289347,"median":-4.571286,"eighty":-2.034537,"marketCap":7672399},{"date":"2025-07-03","current":-0.492879,"twenty":-7.259023,"median":-4.506472,"eighty":-1.991406,"marketCap":7399101},{"date":"2025-07-11","current":-0.528288,"twenty":-7.195283,"median":-4.389384,"eighty":-1.94521,"marketCap":7930653},{"date":"2025-07-18","current":-0.557015,"twenty":-7.170822,"median":-4.18175,"eighty":-1.91115,"marketCap":8361912},{"date":"2025-07-25","current":-0.542818,"twenty":-7.116406,"median":-4.001374,"eighty":-1.881987,"marketCap":8148790},{"date":"2025-08-01","current":-0.462648,"twenty":-7.091556,"median":-3.972293,"eighty":-1.853811,"marketCap":6945276},{"date":"2025-08-08","current":-0.502341,"twenty":-7.039039,"median":-3.955696,"eighty":-1.829566,"marketCap":6318446},{"date":"2025-08-15","current":-1.11677,"twenty":-7.015013,"median":-3.928289,"eighty":-1.810366,"marketCap":14046731},{"date":"2025-08-22","current":-1.175134,"twenty":-7.006256,"median":-3.910018,"eighty":-1.798683,"marketCap":14780832},{"date":"2025-08-29","current":-1.08871,"twenty":-6.960631,"median":-3.889463,"eighty":-1.782371,"marketCap":13693798},{"date":"2025-09-05","current":-1.066138,"twenty":-6.940264,"median":-3.868908,"eighty":-1.769697,"marketCap":13409881},{"date":"2025-09-12","current":-0.906383,"twenty":-6.917299,"median":-3.862331,"eighty":-1.745683,"marketCap":11400489},{"date":"2025-09-19","current":-0.936024,"twenty":-6.885877,"median":-3.848353,"eighty":-1.727072,"marketCap":11773310},{"date":"2025-09-26","current":-0.967225,"twenty":-6.839125,"median":-3.809527,"eighty":-1.460474,"marketCap":12165754},{"date":"2025-10-03","current":-1.053027,"twenty":-6.813143,"median":-3.783279,"eighty":-1.137571,"marketCap":13244974},{"date":"2025-10-10","current":-1.237502,"twenty":-6.788993,"median":-3.727307,"eighty":-1.12949,"marketCap":15565298},{"date":"2025-10-17","current":-1.024946,"twenty":-6.76879,"median":-3.686198,"eighty":-1.120137,"marketCap":12891775},{"date":"2025-10-24","current":-0.939534,"twenty":-6.749312,"median":-3.590621,"eighty":-1.104352,"marketCap":11817460},{"date":"2025-10-31","current":-5.148132,"twenty":-6.716708,"median":-3.589534,"eighty":-1.099571,"marketCap":64753209},{"date":"2025-11-07","current":-1.892719,"twenty":-6.656725,"median":-3.544596,"eighty":-1.101463,"marketCap":23806615},{"date":"2025-11-14","current":-2.446921,"twenty":-6.626601,"median":-3.5023,"eighty":-1.103492,"marketCap":28717059},{"date":"2025-11-21","current":-1.944844,"twenty":-6.606869,"median":-3.463472,"eighty":-1.104352,"marketCap":22824686},{"date":"2025-11-28","current":-2.043621,"twenty":-6.587138,"median":-3.425742,"eighty":-1.107316,"marketCap":23983940},{"date":"2025-12-05","current":-2.35582,"twenty":-6.574276,"median":-3.358472,"eighty":-1.113245,"marketCap":27647903},{"date":"2025-12-12","current":-3.019626,"twenty":-6.553045,"median":-3.316207,"eighty":-1.116199,"marketCap":35438329},{"date":"2025-12-19","current":-2.137793,"twenty":-6.527942,"median":-3.243133,"eighty":-1.119015,"marketCap":25089135},{"date":"2025-12-26","current":-2.080983,"twenty":-6.524653,"median":-3.176227,"eighty":-1.123804,"marketCap":24422414},{"date":"2026-01-02","current":-2.099408,"twenty":-6.511499,"median":-3.101522,"eighty":-1.12949,"marketCap":24638648},{"date":"2026-01-09","current":-2.221728,"twenty":-6.504734,"median":-3.060412,"eighty":-1.12949,"marketCap":26074201},{"date":"2026-01-16","current":-2.13984,"twenty":-6.495056,"median":-3.033553,"eighty":-1.130611,"marketCap":25113161},{"date":"2026-01-23","current":-2.069211,"twenty":-6.49239,"median":-3.01718,"eighty":-1.136,"marketCap":24284265},{"date":"2026-01-30","current":-1.919766,"twenty":-6.454926,"median":-3.013363,"eighty":-1.137646,"marketCap":22530368},{"date":"2026-02-06","current":-1.733982,"twenty":-6.428753,"median":-2.969787,"eighty":-1.161067,"marketCap":20350010},{"date":"2026-02-13","current":-1.899293,"twenty":-6.415174,"median":-2.923378,"eighty":-1.169405,"marketCap":22290108},{"date":"2026-02-20","current":-1.407702,"twenty":-6.41284,"median":-2.923378,"eighty":-1.173092,"marketCap":16520786},{"date":"2026-02-27","current":-1.68406,"twenty":-6.373511,"median":-2.907391,"eighty":-1.18307,"marketCap":19764131},{"date":"2026-03-06","current":-1.666788,"twenty":-6.347157,"median":-2.832023,"eighty":-1.198842,"marketCap":19561422},{"date":"2026-03-13","current":-1.602016,"twenty":-6.337936,"median":-2.800625,"eighty":-1.210211,"marketCap":18801263},{"date":"2026-03-20","current":-1.36668,"twenty":-6.318494,"median":-2.717615,"eighty":-1.227754,"marketCap":16039352},{"date":"2026-03-27","current":-1.31918,"twenty":-6.286175,"median":-2.680541,"eighty":-1.251532,"marketCap":15481902},{"date":"2026-04-02","current":-1.245392,"twenty":-6.265359,"median":-2.664029,"eighty":-1.244158,"marketCap":14454023},{"date":"2026-04-10","current":-1.225823,"twenty":-6.247146,"median":-2.620421,"eighty":-1.218208,"marketCap":14226900},{"date":"2026-04-17","current":-1.164532,"twenty":-6.209886,"median":-2.570403,"eighty":-1.20262,"marketCap":13515555},{"date":"2026-04-24","current":-1.166721,"twenty":-6.171236,"median":-2.563437,"eighty":-1.174026,"marketCap":13540960},{"date":"2026-05-01","current":-1.140453,"twenty":-6.122147,"median":-2.524515,"eighty":-1.165408,"marketCap":13236098},{"date":"2026-05-08","current":-1.118563,"twenty":-6.057883,"median":-2.498422,"eighty":-1.149209,"marketCap":12982046},{"date":"2026-05-15","current":-1.214157,"twenty":-6.044513,"median":-2.460923,"eighty":-1.153587,"marketCap":12982976},{"date":"2026-05-22","current":-1.167077,"twenty":-6.017625,"median":-2.414832,"eighty":-1.147254,"marketCap":12479554},{"date":"2026-05-29","current":-1.095219,"twenty":-5.990544,"median":-2.405465,"eighty":-1.145316,"marketCap":11711174},{"date":"2026-06-05","current":-0.98867,"twenty":-5.981753,"median":-2.388873,"eighty":-1.140453,"marketCap":10571852},{"date":"2026-06-12","current":-0.909378,"twenty":-5.96354,"median":-2.368393,"eighty":-1.137422,"marketCap":9723984},{"date":"2026-06-18","current":-0.928913,"twenty":-5.932317,"median":-2.321954,"eighty":-1.136075,"marketCap":9932863},{"date":"2026-06-26","current":-1.031283,"twenty":-5.925812,"median":-2.245526,"eighty":-1.12949,"marketCap":11027505},{"date":"2026-07-02","current":-1.048976,"twenty":-5.920609,"median":-2.230988,"eighty":-1.121618,"marketCap":11216703},{"date":"2026-07-10","current":-1.241078,"twenty":-5.86727,"median":-2.200744,"eighty":-1.121618,"marketCap":13270846},{"date":"2026-07-17","current":-1.23855,"twenty":-5.742138,"median":-2.185308,"eighty":-1.126332,"marketCap":13243818},{"date":"2026-07-24","current":-1.11975,"twenty":-5.616504,"median":-2.175154,"eighty":-1.119513,"marketCap":11973492},{"date":"2026-07-31","current":-1.0237,"twenty":-5.572644,"median":-2.173796,"eighty":-1.117846,"marketCap":10946421},{"date":"2026-08-07","current":-1.074253,"twenty":-5.54114,"median":-2.162275,"eighty":-1.110773,"marketCap":11486985},{"date":"2026-08-14","current":-0.968492,"twenty":-5.510253,"median":-2.155308,"eighty":-1.103492,"marketCap":10811280},{"date":"2026-08-21","current":-1.427269,"twenty":-5.454128,"median":-2.154445,"eighty":-1.104352,"marketCap":15932609}],"updateTime":1787600458299},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INTS\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1132068598","title":"Intensity Therapeutics重启三阴性乳腺癌术前随机二期临床试验患者治疗（Invincible-4研究）","url":"https://stock-news.laohu8.com/highlight/detail?id=1132068598","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132068598?lang=zh_cn&edition=fundamental","pubTime":"2026-07-15 19:47","pubTimestamp":1784116036,"startTime":"0","endTime":"0","summary":"Intensity Therapeutics, Inc.已重新启动其针对三阴性乳腺癌的随机、术前二期临床试验的患者治疗工作。该试验代号为Invincible-4研究，旨在评估公司核心治疗方案在手术前治疗阶段的有效性与安全性。此次重启标志着临床试验进程步入关键阶段，为后续数据收集与分析奠定了重要基础。研究设计的随机性与术前干预特点，有望为三阴性乳腺癌这一治疗需求迫切的领域提供新的临床证据。公司方面表示，将严格遵循试验方案推进患者入组与治疗，并密切监测相关临床指标。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INTS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196304113","title":"Intensity Therapeutics推进软组织肉瘤与术前三阴性乳腺癌的晚期临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1196304113","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196304113?lang=zh_cn&edition=fundamental","pubTime":"2026-07-01 20:08","pubTimestamp":1782907707,"startTime":"0","endTime":"0","summary":"Intensity Therapeutics, Inc. 近日宣布，其在软组织肉瘤与术前三阴性乳腺癌两个关键领域的晚期临床研究取得了显著进展。针对软组织肉瘤，公司已成功推进其候选药物的后期临床试验阶段，为这一难治性癌症患者带来了新的希望。与此同时，在更具挑战性的三阴性乳腺癌领域，Intensity Therapeutics专注于术前治疗方案的开发，旨在通过新型疗法提高手术成功率并改善患者预后。这些进展不仅有望为患者提供更有效的治疗选择，也可能为Intensity Therapeutics的未来发展奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INTS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153049206","title":"Intensity Therapeutics公司——Int230-6研究完成，患者入组超200例，成果经同行评审发表","url":"https://stock-news.laohu8.com/highlight/detail?id=1153049206","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153049206?lang=zh_cn&edition=fundamental","pubTime":"2026-07-01 20:06","pubTimestamp":1782907604,"startTime":"0","endTime":"0","summary":"Intensity Therapeutics公司宣布，其Int230-6相关研究已经完成，累计入组患者人数超过200名。该研究取得的成果现已通过严格的同行评审程序，并在专业学术期刊上正式发表。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142253659","title":"Intensity Therapeutics发布年中进展，重点阐述Int230-6晚期研发项目与战略合作机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=1142253659","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142253659?lang=zh_cn&edition=fundamental","pubTime":"2026-07-01 20:03","pubTimestamp":1782907414,"startTime":"0","endTime":"0","summary":"Intensity Therapeutics, Inc. 近日发布了其年中业务进展更新，重点聚焦于其核心候选药物Int230-6的晚期临床开发项目，并探讨了潜在的全球战略合作机遇。目前，多项晚期临床试验正在评估其在多种实体瘤中的疗效与安全性。Intensity Therapeutics重申了对推进其研发管线的承诺，并相信Int230-6有望成为肿瘤治疗领域的一个重要进展。公司将继续专注于执行其临床开发战略，同时探索所有可能的合作路径，以推动该创新疗法早日惠及患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INTS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107242718","title":"Intensity Therapeutics, Inc.：Benchmark将目标价调整至12美元，此前为1.50美元，以反映并股影响","url":"https://stock-news.laohu8.com/highlight/detail?id=1107242718","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107242718?lang=zh_cn&edition=fundamental","pubTime":"2026-03-31 19:16","pubTimestamp":1774955774,"startTime":"0","endTime":"0","summary":"投资机构Benchmark近日宣布，对Intensity Therapeutics, Inc.的目标股价作出调整，从原先的1.50美元上调至12美元。此次调整主要基于该公司近期实施的并股操作，旨在更准确地反映其股票实际价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144502083","title":"Intensity Therapeutics公布2025财年业绩亮点及企业动态更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1144502083","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144502083?lang=zh_cn&edition=fundamental","pubTime":"2026-03-28 04:14","pubTimestamp":1774642451,"startTime":"0","endTime":"0","summary":"Intensity Therapeutics, Inc.（以下简称\"公司\"）今日正式披露其2025财年全年财务业绩报告，同步公布年度核心进展与战略规划更新。公司通过系统性数据呈现，全面回顾了本财年在研发管线推进、临床实验成果及资本运营方面的关键节点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100445991","title":"Intensity Therapeutics公司宣布扩大ATM融资机制 旨在提升财务灵活性","url":"https://stock-news.laohu8.com/highlight/detail?id=1100445991","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100445991?lang=zh_cn&edition=fundamental","pubTime":"2026-03-24 04:07","pubTimestamp":1774296425,"startTime":"0","endTime":"0","summary":"根据最新提交给美国证券交易委员会（SEC）的文件显示，Intensity Therapeutics公司已对其现有ATM（按市价发行）融资安排进行了扩展。\n这一战略性举措旨在进一步增强公司的财务灵活性，为未来业务发展及临床试验提供更充足的资金支持。ATM机制允许上市公司在需要时通过承销商向公众发售新股，从而高效地募集资金。\n通过扩大该融资渠道，Intensity Therapeutics能够更灵活地把握市场机遇，支持其创新癌症疗法的研发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INTS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619072158","title":"BUZZ--美国股票走势-Natera、Pacira 生物科学公司、Kezar 生命科学公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2619072158","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619072158?lang=zh_cn&edition=fundamental","pubTime":"2026-03-13 00:00","pubTimestamp":1773331241,"startTime":"0","endTime":"0","summary":".N美东时间11时30分，道琼斯工业平均指数.DJI下跌1.38%，报46,764.08点。标普500指数.SPX下跌1.24%，报6,692.11点；纳斯达克综合指数.IXIC下跌1.61%，报22,349.55点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nL4S4001PO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002232.USD","BBW","INTS","AALG","LU0130102774.USD","JBL","XOMO","MOS","ARES","DG","OWL","TBBK","XOMZ","DAL","KMLI","KZR","WLTH","BX","KKR","LU2065170008.USD","PCRX","IE00B19Z3B42.SGD","GIII","MUR","CF","LUV","RPID","AAL","BK4504","LU0795875169.SGD","SM","CE","UAL","NTRA","MELI","GFS","NOG","CASH","LU0345781412.USD","SG9999014906.USD","DKS","SPRC","CUBI","XOMX","BMBL","GYRE","DOW"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2618318661","title":"BUZZ-乳腺癌药物初显疗效，Intensity Therapeutics 股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2618318661","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618318661?lang=zh_cn&edition=fundamental","pubTime":"2026-03-12 19:40","pubTimestamp":1773315627,"startTime":"0","endTime":"0","summary":"BUZZ-乳腺癌药物初显疗效，Intensity Therapeutics 股价上涨3月12日 - ** 生物技术公司Intensity Therapeutics INTS.O股价盘前上涨约3.5%至8.19美元** 该公司称，其试验性药物INT230-6在一项针对三阴性乳腺癌的小型研究中显示出令人鼓舞的早期结果，这种乳腺癌具有侵袭性，治疗方案有限。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nL4T40014R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INTS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192107848","title":"Intensity Therapeutics公司初步Invincible-4研究显示：INT230-6联合标准疗法病理完全缓解率达71.4%，单独标准疗法为33%","url":"https://stock-news.laohu8.com/highlight/detail?id=1192107848","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192107848?lang=zh_cn&edition=fundamental","pubTime":"2026-03-12 19:34","pubTimestamp":1773315250,"startTime":"0","endTime":"0","summary":"Intensity Therapeutics公司公布的Invincible-4初步研究数据揭示显著疗效差异：在接受其核心候选药物INT230-6与标准疗法联合治疗的患者组中，病理完全缓解率高达71.4%，而仅接受标准疗法对照组的缓解率则为33%。这一数据凸显了INT230-6在联合用药方案中的巨大治疗潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167962781","title":"Intensity Therapeutics公司提议修改方案：降低药物剂量并采用单次Int230-6注射","url":"https://stock-news.laohu8.com/highlight/detail?id=1167962781","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167962781?lang=zh_cn&edition=fundamental","pubTime":"2026-03-12 19:32","pubTimestamp":1773315132,"startTime":"0","endTime":"0","summary":"Intensity Therapeutics公司近日提出一项方案修订，计划减少药物使用量并改为单次注射Int230-6。这一调整旨在优化治疗方案，可能提升患者的治疗体验并降低潜在风险。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INTS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180395853","title":"Intensity Therapeutics Inc 向瑞士药监局及伦理委员会提交方案修订，拟重启Invincible-4研究入组","url":"https://stock-news.laohu8.com/highlight/detail?id=1180395853","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180395853?lang=zh_cn&edition=fundamental","pubTime":"2026-03-12 19:31","pubTimestamp":1773315077,"startTime":"0","endTime":"0","summary":"Intensity Therapeutics Inc 已正式向瑞士药品监督管理局（Swissmedic）及瑞士伦理委员会提交临床试验方案修订申请，旨在恢复其代号为“Invincible-4”的研究项目患者入组工作。此次提交的修订内容涉及对研究方案的调整，公司期待在获得监管批准后，尽快重新启动受试者招募。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166093020","title":"Intensity Therapeutics, Inc. 公布其二期术前三阴性乳腺癌Invincible-4研究最新进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1166093020","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166093020?lang=zh_cn&edition=fundamental","pubTime":"2026-03-12 19:31","pubTimestamp":1773315077,"startTime":"0","endTime":"0","summary":"Intensity Therapeutics, Inc. 近期发布了关于其正在进行的二期临床试验——Invincible-4研究的最新信息。该研究主要针对术前三阴性乳腺癌患者，旨在评估新型疗法的安全性与有效性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INTS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":13,"code":"91000000","status":"200"}]}}